Escolar Documentos
Profissional Documentos
Cultura Documentos
Impaired gas exchange related to fluid and exudate accumulation at the capillary-alveolar membrane as evidenced by
decreased breath sounds, abnormal arterial blood gases, restlessness, confusion, and somnolence.
1. Maintains adequate alveolar oxygen-carbon dioxide exchange
2. Clears lungs of fluids and exudates
OUTCOMES (NOC)
Respiratory Status: Gas Exchange
Auscultate breath sounds, noting areas of decreased/absent ventilation, and presence of adventitious
sounds to obtain ongoing data on patients response to therapy.
Monitor rate, rhythm, depth, and effort of respirations to determine respiratory status.
Monitor for increased restlessness, anxiety, and air hunger to detect increasing hypoxemia.
Monitor patients ability to cough effectively to promote secretion removal.
PaO2 _____
PaCO2 _____
Oxygen saturation _____
Chest x-ray findings _____
Measurement Scale
Oxygen Therapy
Administer supplemental oxygen as ordered to promote adequate oxygenation.
Set up oxygen equipment and administer through a heated, humidified system to prevent drying of the
respiratory tract.
Monitor the effectiveness of oxygen therapy (e.g., pulse oximetry, ABGs).
Monitor patients anxiety related to need for oxygen therapy to provide explanations and reassurance.
Periodically check oxygen delivery device to ensure that the prescribed concentration is being delivered.
Measurement Scale
1 = Severe
2 = Substantial
3 = Moderate
4 = Mild
5 = None
NURSING DIAGNOSIS
Ineffective breathing pattern related to inflammation and pain as evidenced by dyspnea, tachypnea, nasal flaring, altered
chest excursion
Demonstrates effective respiratory rate, rhythm, and depth of respirations
PATIENT GOAL
OUTCOMES (NOC)
Respiratory Status: Ventilation
Measurement Scale
1 = Severe deviation from normal range
2 = Substantial deviation from normal range
3 = Moderate deviation from normal range
4 = Mild deviation from normal range
5 = No deviation from normal range
Measurement Scale
1 = Severe
2 = Substantial
3 = Moderate
4 = Mild
5 = None
553
Acute pain related to inflammation and ineffective pain management and/or comfort measures as evidenced by patient report
of pleuritic chest pain and presence of pleural friction rub, shallow respirations
Reports control of pain following relief measures
PATIENT GOAL
OUTCOMES (NOC)
Pain Control
Measurement Scale
1 = Never demonstrated
2 = Rarely demonstrated
3 = Sometimes demonstrated
4 = Often demonstrated
5 = Consistently demonstrated
EVALUATION
The expected outcomes for the patient with pneumonia are presented in NCP 28-1.
TUBERCULOSIS
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis. It usually involves the lungs, but can also
occur in other parts of the body. TB is the worlds second most
common cause of death from infectious disease, after HIV/
acquired immunodeficiency syndrome (AIDS).1 Worldwide,
TB occurs disproportionately in the poor, the underserved,
and minorities. In the United States persons at risk include the
homeless, residents of inner-city neighborhoods, foreign-born
persons, older adults, those in institutions (long-term care facilities, prisons), IV injecting drug users, persons at poverty level,
and those with poor access to health care.12 Immunosuppression from any etiology (e.g., HIV infection, malignancy, longterm corticosteroid use) increases the risk of TB infection. The
prevalence of TB is higher in areas of the United States where
there is a large population of Native Americans, such as Arizona
and New Mexico (see Cultural and Ethnic Health Disparities
box). Health care workers with increased exposure to TB are
considered at high risk.
The incidence of TB worldwide declined until the mid-1980s
when HIV disease emerged. The major factors that have contributed to the resurgence of TB have been (1) high rates of TB
among patients with HIV infection and (2) the emergence of
multidrug-resistant (MDR) strains of M. tuberculosis. The rates
of TB are now slowly declining again.
Once a strain of M. tuberculosis develops resistance to isoniazid and rifampin, it is defined as multidrug-resistant tuberculosis
(MDR-TB). Resistance results from several problems, including
incorrect prescribing, lack of public health case management,
and patient nonadherence to the prescribed regimen.13
with the infected person. TB is not highly infectious, and transmission usually requires close, frequent, or prolonged exposure.
The disease cannot be spread by hands, books, glasses, or dishes.
The very small droplets, 1 to 5 m in size, contain M. tuberculosis. Because they are so small, the particles remain airborne
indoors for minutes to hours. Once inhaled, these small particles
lodge in the bronchiole and alveolus. Factors that influence the
likelihood of transmission include the (1) number of organisms expelled into the air, (2) concentration of organisms (small
spaces with limited ventilation would mean higher concentration), (3) length of time of exposure, and (4) immune system of
the exposed person. M. tuberculosis replicates slowly and spreads
via the lymphatic system. The organisms find favorable environments for growth primarily in the upper lobes of the lungs, kidneys, epiphyses of the bone, cerebral cortex, and adrenal glands.
Classification
The classification system for TB14 is presented in Table 28-8. TB
infection occurs when the bacteria are inhaled but there is an
effective immune response and the bacteria become inactive.
The majority of people mount effective immune responses to